Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of ...
Implantable Cardioverter Defibrillator (ICD)
This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).
November 25, 2017 — Sitting in, or standing close to the charging port of a Tesla electric vehicle did not trigger a ...
October 30, 2017 — The American College of Cardiology, along with the American Heart Association and the Heart Rhythm ...
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...
September 22, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-condi ...
September 11, 2017 — According to the latest market study released by Technavio, the global electrophysiology ...

August 29, 2017 — The U.S. Food and Drug Administration (FDA) approved a firmware update that is now available to reduce ...
July 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX ...
July 13, 2017 — Experts in heart failure management gathered in June to discuss varying scientific evidence in their ...
July 6, 2017 — Two predictive models may help cardiologists decide which patients would most benefit from an implantable ...
July 3, 2017 — Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation ...
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for ...

Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...
June 20 2017 — Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the ...
Lucas Boersma, M.D., Ph.D., FESC, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands, discusses how subcutaneous ...